Showing results (1681-1690 of 1,948) with videos related to

Sort By:
Pageof 195
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 14, 2004
Phase III study of adjuvant chemotherapy and radiation therapy compared with chemotherapy alone in the surgical adjuvant treatment of colon cancer: results of intergroup protocol 0130James A Martenson, Christopher G Willett, Daniel J Sargent, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 2, 2014
KRAS codon 12 and 13 mutations in relation to disease-free survival in BRAF-wild-type stage III colon cancers from an adjuvant chemotherapy trial (N0147 alliance)Harry H Yoon, David Tougeron, Qian Shi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 9, 2014
Association of age with survival in patients with metastatic colorectal cancer: analysis from the ARCAD Clinical Trials ProgramChristopher H Lieu, Lindsay A Renfro, Aimery de Gramont, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2003
Phase I and pharmacokinetic study of two different schedules of oxaliplatin, irinotecan, Fluorouracil, and leucovorin in patients with solid tumorsMatthew P Goetz, Charles Erlichman, Anthony J Windebank, et al.
Journal of the American Chemical Society|March 17, 2020
Native Zinc Catalyzes Selective and Traceless Release of Small Molecules in β-CellsMiseon Lee, Basudeb Maji, Debasish Manna, et al.
Gastroenterology|September 6, 2006
Prognostic impact of microsatellite instability and DNA ploidy in human colon carcinoma patientsFrank A Sinicrope, Rafaela L Rego, Kevin C Halling, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2016
CALGB 80403 (Alliance)/E1206: A Randomized Phase II Study of Three Chemotherapy Regimens Plus Cetuximab in Metastatic Esophageal and Gastroesophageal Junction CancersPeter C Enzinger, Barbara Ann Burtness, Donna Niedzwiecki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2009
Phase III noninferiority trial comparing irinotecan with oxaliplatin, fluorouracil, and leucovorin in patients with advanced colorectal carcinoma previously treated with fluorouracil: N9841George P Kim, Daniel J Sargent, Michelle R Mahoney, et al.
Pageof 195